To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|ER Positive Breast Cancer|HER2-negative Breast Cancer
Interventions: DIAGNOSTIC_TEST: Thymidine kinase activity
Sponsor: Fondazione Sandro Pitigliani
Collaborators: Clinical Research Technology S.r.l.